OM202JP Clinical Study of KNP2002

Inclusion Criteria: * Subjects aged 15 to 49 years old * Subjects with common warts on the upper or lower limb * Subjects who agree to contraception from obtaining consent to 4 weeks after the end of administration * Subjects who have given their voluntary written consent to participate in this clinical trial Exclusion Criteria: * Subjects with 5 or more warts on the upper or lower limbs * Subjects who are scheduled to undergo treatment such as physical therapy or chemotherapy for warts * Subjects with a history of allergy to topical skin preparations * Subjects with a history of malignant tumor within 5 years before administration of study drug * Subjects with any of the following diseases: Malignant tumor; Serious heart disease; Poorly controlled diabetes/hypertension * Women who are pregnant, may become pregnant, or are breastfeeding